TABLE 1.
Characteristics of the participants (n = 12).
| Characteristics | |
|---|---|
| Male/female (n) | 5/7 |
| Age (years) | 49.9 ± 11.7 |
| Body weight (kg) | 66.1 ± 15.3 |
| Height (cm) | 170 ± 10 |
| Body mass index (kg/m2) | 23.3 ± 5.2 |
| Dialysis vintage (years) | 7.9 ± 6.6 |
| Cause of end stage renal disease | |
| Alport syndrome | 1 |
| Autosomal dominant polycystic kidney disease | 1 |
| Chronic urate nephropathy | 1 |
| Diabetic kidney disease | 1 |
| Hypertensive nephrosclerosis | 8 |
| Clinical parameters on pharmacokinetic study | |
| Dialysis day | |
| Systolic blood pressure (mmHg) | 143.5 ± 20.3 |
| Diastolic blood pressure (mmHg) | 72.0 ± 11.4 |
| Mean arterial pressure (mmHg) | 87.9 ± 30.1 |
| Pulse (bpm) | 72 ± 13 |
| Body temperature (°C) | 36.3 ± 0.3 |
| Blood flow (mL/min) | 320.8 ± 33.4 |
| Dialysate flow (mL/min) | 550.0 ± 100.0 |
| Ultrafiltration volume (mL) | 3.054 ± 828 |
| Hemoglobin (g/dL) | 11.2 ± 0.5 |
| Blood urea nitrogen (mg/dL) | 79.4 ± 6.9 |
| Creatinine (mg/dL) | 7.7 ± 0.8 |
| Aspartate aminotransferase (U/L) | 28.2 ± 3.3 |
| Alanine transaminase (U/L) | 28.4 ± 1.8 |
| Albumin (g/dL) | 3.8 ± 0.2 |
| Non‐dialysis day | |
| Systolic blood pressure (mmHg) | 141.7 ± 18.4 |
| Diastolic blood pressure (mmHg) | 78.2 ± 12.0 |
| Mean arterial pressure (mmHg) | 99.4 ± 12.1 |
| Pulse (bpm) | 70 ± 10 |
| Body temperature (°C) | 36.6 ± 0.2 |
Note: Data are presented as mean ± standard deviation unless otherwise stated.